Earlier quoted context omitted.
The cost of the aspirin depends on these things lol. Look up 340B. There is a drug called Oncaspar. It's >$16,000 for one patient, and 5 cents for another (acquisition cost). Same drug, widely different acquisition cost.
When two pills coming from the same company are being made at the same time on the same machines, then they both cost the same. It's pretty obvious that the patient status changes nothing about that. However, the hospital's acquisition cost is variable because you're further down the supply chain and you're seeing the exact same kinds of arbitrary behind-the-scenes price swings that this article is talking about. It…
Seems like 340B (I hadn’t heard of this before, thanks!) may have been created with recognition of this inelasticity.
If we can limit prices this way, all it would take are a few more laws to put more price limits in place.